| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.09. | Picard Medical Aktie bricht ein: Spekulative Gewinne weichen fundamentalen Sorgen | 7 | Investing.com Deutsch | ||
| 24.08. | Why Is Picard Medical Stock Gaining Monday? | 12 | Benzinga.com | ||
| 20.08. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.08. | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | 227 | GlobeNewswire (Europe) | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| 19.08. | Picard Medical reports Q2 results | 2 | Seeking Alpha | ||
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 19.08. | Picard Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17.08. | Picard Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 31.07. | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | 1 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 | 2 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical regains NYSE compliance | 2 | Seeking Alpha | ||
| 27.07. | Picard Medical regains compliance with NYSE American listing | 1 | Investing.com | ||
| 27.07. | Picard Medical, Inc.: Picard Medical Receives NYSE American Acceptance of Compliance Plan | 285 | GlobeNewswire (Europe) | TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first... ► Artikel lesen | |
| 22.07. | Picard Medical announces 1-for-50 reverse stock split to maintain NYSE American listing; stock slips | 3 | Seeking Alpha | ||
| 22.07. | Picard Medical approves 1-for-50 reverse stock split | 4 | Investing.com | ||
| 22.07. | Picard Medical, Inc.: Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance | 285 | GlobeNewswire (Europe) | -Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the... ► Artikel lesen | |
| 21.07. | Picard Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.07. | Picard Medical's artificial heart platform reviewed in journal | 2 | Investing.com | ||
| 15.07. | Fachzeitschrift beleuchtet Plattform für künstliches Herz von Picard Medical | 2 | Investing.com Deutsch | ||
| 15.07. | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | 167 | GlobeNewswire (Europe) | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 13.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 3 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 24,740 | -0,80 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| BLUEJAY DIAGNOSTICS | 0,860 | 0,00 % | Bluejay Diagnostics, Inc. - 8-K, Current Report | ||
| TREACE MEDICAL CONCEPTS | 4,630 | 0,00 % | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Second Quarter 2026 Financial Results | PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| HEARTFLOW | 49,540 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | -0,05 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| ALIGNMENT HEALTHCARE | 12,935 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| BASEL MEDICAL GROUP | 7,180 | +0,56 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | +0,10 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| FRESENIUS | 45,410 | -0,65 % | AKTIE IM FOKUS: Fresenius ziehen an Dax-Spitze - UBS äußert sich zuversichtlich | FRANKFURT (dpa-AFX) - Die Aktien von Fresenius haben am Dienstag von einem positiven Analystenkommentar profitiert und so vorerst eine achttägige Verlustserie beendet. Die Papiere des Medizinkonzerns... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,025 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| STARLING ONCOLOGY INSTITUTE | 6,520 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | +0,03 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | -0,12 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,900 | +0,86 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen |